繁體中文 简体中文 Sitemap Previous Page
Research and Development
Production
Marketing
Innovative Resolution & Quality Insistence
Taiwan Biotech Co., Ltd. heeds the government development policy by upgrading itself from a GMP certified manufacture to cGMP in 2005 and our products have accredited with the National Pharmaceutical Quality Award.

The Taoyuan main production plant
The Taoyuan plant encompasses an expansive 324,000 square foot facility that houses four production plants including the parenteral plant, BFS (Blow-Fill-Seal) parenteral plant, solid product manufacturing plant and TDDS (Transdermal Drug Delivery System) plant.

The parenteral plant marks the longest running operations in company history as it began from the earlier days’ production of glass bottles and injection syringes to the present day’s fully automated operations for producing perfect injection fluid, noticeably of the 500 c.c. injectable fluid. Manufactured under the automated KT production line brought in from Japan offers a fully automated production process from ultrasonic rinsing, auto filling and capping, sterilization, automatic foreign particle detection, automatic labeling, and boxing. The hemo-dialysis fluid produced by the parenteral plant with high standard and production know-how share more than 45% of the market demand.

In 1979, we took the lead in Asia for introducing a Bottle Pack machine from Rommelag Switzerland, offering an automatic production from PE blowing, filling, and sealing to produce sterile parenteral agents including injection, inhalation solution, eye care and ophthalmic treatment solution which remained uncontested across Taiwan. All these products that come with the advantages of sterile, unit dosage, free of preservatives and easy carry, the PE material used for container is of high medical grade, safe and free of toxicity to warrant higher safety than the conventional glass ampoule and sparing the risk of getting hurt by glass cuts which happened sometime when glass ampoule is used.

The solid product manufacturing plant is firm’s emerging latecomer, supported by automation, high capacity output and with excellent quality to produce 78 BE products before 2005, Taiwan Biotech Co., Ltd. installed a high speed encapsulation machine equipped with weight checker from Bosch, Germany, which could produce 150,000 capsules per hour with an individual weight checking to ensure weight of each capsule is a control range.

The TDDS (Transdermal Drug Delivery System) plant mainly produces suspend release patch, the nicotine patch that currently launched in the market is the leading formula developed by Taiwan Biotech Co., Ltd. in synchronization with premier world producer, and is the only one containing medicine in Taiwan.

Biotech Production Plant at the Hsinchu Science-based Industrial Park
Plant located in the Hsinchu Science-based Industrial Park concentrates in the research and
development of health beneficial biotech foods and Chinese herbal medicine, noticeably of the
successful extraction of active substances derived from the American ginseng working with the
Pharmaceutical Technology Center that offers beneficial yield for gastrointestinal and bodily
health.

The Taoyuan API Plant
The Active Pharmaceutical Ingredients plant primarily produces Cephalosporin antibiotics and intermediate, noticeably of the Cephalexin that has been certified by the U.S. FDA in 1994.

The Kuan Yin Plant
The newly acquired plant provides cephalosporin products in form of tablets, capsules, and injections which support Taoyan main plant in mapping out a comprehensive product portfolio. Also the new plant is fitting the world trend of individual production site of antibiotics.

The Veterans Pharmaceutical Plant
Recently acquired the factory management authority, mainly supplies gastrointestinal and respiratory treatment drugs, and skin improvement products.

|
22, Jie Shou Road,Taoyuan 33062,Taiwan   TEL: 886-3-3612131   FAX: 886-3-3670029   E-mail: admit-hr@sintong.com   Copyright© 2017 Taiwan Biotech Co.,Ltd.